Actinium Pharmaceuticals
ATNM
ATNM
42 hedge funds and large institutions have $2.09M invested in Actinium Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $3.12M → $2.09M (-$1.03M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
42
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$161K | |
| 2 | +$38K | |
| 3 | +$13K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$8.4K |
Top Sellers
| 1 | -$516K | |
| 2 | -$159K | |
| 3 | -$147K | |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$43K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18.9K |